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Abstract 
Dimerization Specificities of Leucine Zipper Mutants 
Jennifer Dawn Rieker, (Dr. James C. Hu) University Undergraduate Fellow, 1997-1998, 
Texas AkM University, Department of Biochemistry and Biophysics 
The dimerization specificity of a leucine zipper is partially determined by the 
interactions of charged amino acids on the surfaces of dimer interfaces (e and g positions). 
A series of e and g position GCN4 mutants has been described that do not dimerize with 
the wild-type GCN4 but are able to dimerize with each other. Two hydrophobic leucine 
residues present in the wild-type GCN4 leucine zipper are suspected to be causing this 
difference in dimerization specificity. To determine the importance of these leucine 
residues in dimerization specificity, I constructed a series of mutants in which the leucine 
residues were substituted with alanine. The dimerization specificity of these mutants was 
determined based on the phenotypes of cells expressing wild-type and dominant negative X 
repressor-leucine zipper fusion proteins. Cells that were immune to infection by phage X 
contain homodimeric fusion proteins. Cells that were sensitive to infection by phage ), are 
forming heterodimeric fusion proteins, The two leucine residues in the wild-type GCN4 
leucine zipper are not sufficient to explain the difference in dimerization specificity. 
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The amino acid sequence of a protein determines whether or not it will interact 
with another protein. The model used in our lab for studying protein-protein interactions 
is the leucine zipper. The leucine zipper is a structural motif consisting of two u-helices 
coiled together. It allows two proteins to dimerize when the a-helix of one protein 
monoiner coils together with the n-helix of another protein monomer. The leucine zipper 
is required for dimerization in a class of DNA binding transcription factors (bZIP 
proteins). Landschulz er. al. [1988] showed that these proteins consist of two structural 
domains, one for DNA binding and the other for dimerization. The dimerization of bZIP 
proteins is important for their activities as activators or repressors of transcription. The 
natural proteins containing leucine zippers are very specific, which means they will only 
dimerize with a few other proteins. Since the leucine zippers are ubiquitous in nature, the 
specificity of dimerization is important to our understanding of the regulation of 
transcription. 
The structure of the leucine zipper was first described by Landschulz [1988], but 
the a-helices he suggested were antiparallel. X-ray crystallography has shown that the a- 
helices are parallel [1991]. The a-helix of each monomer is only 30 to 40 amino acids 
long. It contains a leucine residue every seventh position (d) over four to five heptad 
repeats (Fig. 1). Each heptad forms two turns of the a-helix. The residues of one 
inonomer are labeled abcdefg and the corresponding residues of the other monomer are 
labeled a'b'c'd'e f'g'. The a, d, e, and g positions form the interface where the two n- 
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helices come together. The a position contains mostly hydrophobic residues, while the d 
position contains the leucine residues. Two monomers form a dimer by joining on the 
hydrophobic surface, with the leucines forming a zipper. The e and g positions contain 
mostly charged residues which can stabilize the leucine zipper by forming salt bridges 
between the e position of one heptad and the g' position of the next heptad. 
The leucine zipper allows the protein to form homodimers and heterodimers. 
Homodimers contain two subunits of the same protein. Heterodimers contain two 
subunits from different proteins. The formation of heterodimers allows nature to make a 
large number of protein dimers by mixing and matching just a small number of monomers. 
Vinson et. al. (1993 A) studied the formation of heterodimers by looking at the e and g 
positions of 20 bZIP proteins. He suggested that homodimers would form if the residues 
at the e and g positions in one heptad were of opposite charges. IF the residues were of 
the same charge, then the formation of a heterodimer with a protein that has residues of 
opposite charge would be favored. Using this hypothesis, Vinson was able to predict 
which monomers would dimerize. 
Zeng applied Vinson's hypothesis to a series of mutants at the e and g positions of 
the GCN4 leucine zipper [1997A]. The mutants contain different combinations of four 
charged or neutral amino acids, threonine, lysine, glutamic acid and alanine, at the e and g 
positions (Table 1). They differ from the wild-type GCN4 protein by 2 to 8 amino acids. 
The mutants were tested to see iF they would form heterodimers or homodimers with each 
other and with the wild-type. Zeng was not able to predict the dimerization specificity of 
the mutants based on Vinson's hypothesis. He found that predicting the dimerization 
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specificity of mutants was more complicated than looking just at the charge interactions of 
amino acids at the e and g positions. His results did show that the mutants were 
promiscuous, meaning they dimerized with each other. The wild-type was more specific, 
meaning it would only dimerize with itself and not with the mutants. These results show 
that there is a difference in dimerization specificity between the wild-type and the mutants. 
The differences in the amino acid sequence of the mutant and wild-type leucine zippers 
must account for this difference in specificity. The most noticeable difference in the 
sequences is that the wild-type zipper contains two leucines at positions e13 and g29. 
This is unusual because leucine is a hydrophobic residue. Usually the e and g positions 
contain charged residues. 
I constructed two series of mutants to test the effect of these leucines on the 
dimerization specificity. The first series of mutants, the alanine mutants, was constructed 
by changing the wild-type zipper so it contains alanine instead of leucine at either position 
e13, g29, or both (Table 2). This mutation is referred to as a molecular haircut because it 
removes the long hydrophobic side chain of leucine and replaces it with the methyl group 
of alanine (Fig. 2). Alanine was also chosen because it was one of the amino acids used to 
construct the original series of mutants. The specificity of each of these mutants was 
tested with the wild-type GCN4, each of the other rnutants, and each of the original 
mutants from Zeng's work. The working hypothesis suggests that if the leucines are 
causing the difference in dimerization specificity, then the alanine mutants will be able to 
dimerize with the original series of mutants and will not be able to dimerize with wild-type 
GCN4. The results of the specificity assay showed that the mutants were able to dimerize 
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with the wild-type but not with the original set of mutants. These results indicate that the 
leucine residues at el3 and g29 do not have an affect on the dimerization specificity. 
The second series of mutants, the leucine mutants, was constructed by introducing 
leucines into three of the original mutants at positions which contain alanine residues 
(Table 3). Two of the original mutants, s26 and s67, contain 2 alanine residues, and one, 
s20, contains 3 alanine residues. The working hypothesis suggests that if the leucines are 
responsible for the difference in dimerization specificity, then the leucine mutants will be 
able to dimerize with the wild-type and will not be able to dimerize with the original series 
of mutants. The specificity assays on these mutants have not been done yet. 
Materials and methods 
Consrrucrion of zipper seqwences 
The series of alanine mutants was made by substituting alanine for leucine at 
positions e13 (AL), gZ9 (LA) or both (AA) in the wild-type GCN4 zipper. Four oligos 
coding for the mutant and wild-type leucine zippers were ordered &om Genosys (Table 4). 
The first oligo, L13A N-terminal, codes for the ¹erminal half of the leucine zipper and 
contains a Sall site and the L13A mutation. The second oligo, L29A C-terminal, codes for 
the C-terminal half of the zipper and contains a BamHI site and the L29A mutation. The 
third oligo, WT N-terminal, codes for the ¹erminal of the wild-type GCN4 zipper and 
contains a Sall site. The fourth oligo, WT C-terminal, codes for the C-terminal of the 
wild-type GCN4 zipper and contains a BonrHI site. The oligos were resuspended in 
300pL of TE (10mM Tris HC1 pH 7. 5, 1mM EDTA) and then purified on 10'/o acrylamide 
gel (5(Bio urea, 1X TBE). 150lrL of DNA was mixed with 50p L Sequenase Stop Solution 
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(95 lo formamide, 20mM EDTA, bromphenol blue and xylene cyanol). The DNA was 
loaded onto the gel and run at 25W for 3 hours. The bands were visualized using UV 
shadowing. The desired band was cut trom the gel and the DNA was eluted in 0. 5mL of 
0. 3M NaOAc, 5ltM EDTA overnight at 37'C. The pieces of the gel were removed by 
filtering the solution through empty Wizard miniprep columns. The pieces were washed 
with 0. 5mL of 0. 3M NaOAc and filtered again. The overall eluate was -lmL of 0. 3M 
NaOAc containing the DNA. The DNA was concentrated by ethanol precipitation and 
resuspended in 100ltL TE. The concentration of the DNA was determined by measuring 
the OD260 and OD280. The DNA was then diluted with TE to 10ltM stocks to be used 
in the annealing and extending reactions. The ¹erminal and C-terminal oligos overlap by 
9 nucleotides so they can be used as mutual primers. Four annealing reactions were set up 
to make the three mutants and the wild-type. Mixing L13A N-terminal and WT C- 
terminal made the L13A mutant (AL) with a Sall site on the 5' end and a BamHI site on 
the 3' end. Similarly, mixing WT N-terminal and L29A C-terminal makes the L29A 
mutant (LA) with a Sall site on the 5' end and a BamHI site on the 3' end. The double 
mutant (AA) was made by mixing L13A N-terminal and L29A C-terminal. The wild-type 
zipper (LL) is made by mixing WT N-terminal and WT C-terminal. Each of the annealing 
reactions contained 1 p M of each oligo, 1X Sequenase buffer, 0. 25ltM dNTPs, and 10mM 
DTT in a 100', L reaction. The annealing reactions were done by heating to 70 C for one 
minute and cooling by 1 C per 15 seconds to O'C. Atter annealing the oligos, they were 
extended by the addition of 13 units of Sequenase T7 DNA polymerase v2. 0 to each 
annealing reaction to give double stranded DNA coding for all three mutant and the wild- 
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type GCN4 zippers. The double stranded DNA was then digested with Sall and BamHI. 
Each digestion reaction contained approximately IOng of extended DNA, I X Restriction 
buffer (100mM Tris HC1 pH 7. 5, 100mM EDTA), 1X B SA, 150mM NaCl, 1 mM DTT, 
and 10 units each of Sall and BamHI in a 100pL reaction. The digestions were carried 
out at 37'C for two hours. The DNA was concentrated by ethanol precipitation. The 
DNA was resuspended in 20pL of TE. A sample of the digested DNA was run on a 12/o 
acrylamide gel to check the purity of the digest and to estimate the concentration of DNA. 
The series of leucine mutants was made by substituting leucine for alanine in three 
mutants from the original series (Table 3). The three mutants selected were s20, s26, and 
s67. These three mutants are referred to as s20L, s26L and s67L, respectively. Six oligos 
were ordered Irom Genosys to code for the three new mutants (Table 4). The first oligo, 
s20L ¹erminal, codes for the N-terminal half of s20L and contains a Sall site. The 
second oligo, s20L C-terminal, codes for the C-terminal half of s20L and contains the 
A20L, A22L, and A29L mutations and a BamHI site. The third oligo, s26 ¹erminal, 
codes for the N-terminal half of s26L and contains the A6L mutation and a Sall site. The 
fourth oligo, s26L C-terminal, codes for the C-terminal half of s26L and contains the 
A20L mutation and a BamHI site. The fifth oligo, s67 ¹erminal, codes for the N- 
terminal half of s67L and contains a Sall site. The sixth oligo, s67L C-terminal, codes for 
the C-terminal half of s67L and contains the A27L and A29L mutations and a BamHI site. 
The N-terminal and C-terminal oligos of each mutant overlap by nine nucleotides. The 
oligos were purified using the same methods as the alanine mutants. The DNA 
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concentration was measured and the oligos were annealed, extended and digested 
following the same protocol described for the alanine mutants. 
Construction of the repressor fusion protei ns 
In order to use the heterodimer specificity assay, these leucine zipper sequences 
were cloned into plasmids with the cI' and dominant negative fusion proteins. For the cI' 
fusion protein constructs of the alanine mutants, the double stranded DNA fragments 
containing the leucine zipper sequences were cloned between the Sall and BamHI sites of 
pXZ240. pXZ240 is identical to p JH391 [1993B], except it expresses cl' fusions from the 
p7107 promoter, a constitutive mutant of the lacUV5 promoter. It also has the ampicillin 
resistance gene. pXZ240 was digested at 37'C for two hours with Sall and BamHI in a 
reaction containing 100ng of pXZ240, 1X Restriction bufFer, 1X BSA, 150mM NaC1, 
lmM DTT, and 10 units of Sall and BamHI in a 100ltL reaction. pXZ240 was then gel 
purified on a 14/o TPE agarose gel. A 100ltL digestion reaction was mixed with 10pL of 
tracking dye (0. 6g Ficol 400, 75mg bromphenol blue, 75mg xylene green, I'/o SDS, and 
0. 1M EDTA) and loaded on the gel. The gel ran for 2 hours at 100V. The DNA was 
visualized with ethidium bromide. The desired band was cut from the gel and the DNA 
was eluted using the Gene Clean protocol. The band of DNA was weighed and three 
times the volume of NaI was added. The mixture was incubated at 55'C until the agarose 
melted. 5ltL of glass milk was added and the solution was incubated on ice for 10 
minutes. The solution was spun in a microfuge for 10 seconds and the supernatant was 
removed. The pellet was resuspended in 500ltL of NEW solution. The solution was spun 
10 seconds, the supernatant removed and the pellet was resuspended in 500lrL NEW 
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solution. The solution was spun 10 seconds and the pellet was resuspended in 25ltL of 
TE. The solution was incubated 5 minutes at 55'C and then spun 30 seconds. The 
supernatant was saved in a new tube and the pefiet was resuspended in 25', L TE. The 
incubation and spinning were repeated and the supernatant saved. The total volume of 
DNA in the end was 50ltL. A sample of the purified DNA was run on a 1 /o TBE agarose 
gel and the concentration of DNA was estimated visually by comparing the intensity of the 
ethidium bromide stained band to the marker bands. 100ng of pXZ240 and 50ng of the 
zipper sequence were ligated together using 0. 1 units of T4 ligase in a reaction containing 
I X ligase buffer(0. 1M Tris HCl pH 7. 5, 10mM MgClz, 1 mM ATP, and 25p g/mL BSA) 
and 20mM DTT in a 100p, L reaction. The ligation reactions were carried out at room 
temperature overnight. The ligated plasmids were then transformed into E. coli strain 
AG1688 using electroporation (AG1688 is MC1061 F'128 lacP lacZ:: Tn5) [1993B]. To 
select for the desired plasmid, the transformed cells were plated on LB plates containing 
200ltg/mL of ampicillin. Colonies that grew on these plates were tested for immunity to 
phage iLKH54 by cross-streaking. A line of phage was plated down the center of an LB 
ampicillin plate. Transformed colonies were streaked across the line of phage. Streaks 
that were immune to the phage were selected as the desired candidates. The sequence of 
the candidates was confirmed by dideoxy sequencing. One correct candidate of each 
mutant and the wild-type was used to make the dominant negative fusions and in the 
specificity assay. 
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For the dominant negative fusion protein constructs, the mutant and wild-type 
zipper fragments were subcloned from the cl' constructs into a SaII-BamHI cut backbone 
of pXZ610. pXZ610 expresses the dominant negative fusion proteins from the /ac 
promoter. The DNA binding domain of 3, cl repressor has a glutamine to leucine mutation 
at position 44 and an isoleucine to serine mutation at position 84. The linker region 
contains a Flag-M2 epitope tag (IBI). pXZ610 also has the tetracycline resistance gene. 
The ligated plasmids were transformed into E. coli strain AG1688 using electroporation. 
To select for the desired plasmid, the transformed cells were plated on LB plates 
containing 20ltg/mL of tetracycline. Colonies that grew on these plates were selected as 
candidates. The sequence of the candidates was confirmed by dideoxy sequencing. One 
correct candidate of each mutant and the wild-type was used in the specificity assay. 
For the leucine mutants, only the cI' fusion protein of the s20 mutant has been 
made. The mutated zipper sequence was cloned between the Sall and BamHI sites of a 
purified digest of pXZ240. Transformed colonies were selected by plating on LB 
ampicillin plates. The colonies that grew were tested for innnunity to J, KH54 by cross- 
streaking. Immune colonies were selected as candidates and sequenced by the dideoxy 
method. One correct candidate has been identified and will be used to construct the 
dominant negative fusion and in the specificity assay. 
Several control plasmids were also used in the specificity assays. The ampicillin 
resistant controls are p JH706, pXZ1130, and pAH4083. p JH706 contains the DNA 
binding domain of the 434 repressor fused to the GCN4 leucine zipper so it cannot confer 
immunity to phage J. . Any tetracycline resistant plasmid paired with p JH706 will be 
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sensitive to phage I, . pXZ1130 and pAH4083 have the ¹erminal domain of cI repressor 
fused to an a position mutant of the GCN4 leucine zipper [1997B]. The a position 
sequence of pXZ1130 is IINI, and of pAH4083 is INNI. These mutants are known to be 
immune to infection when paired with the wild-type. They are also known to be able to 
titrate themselves so they will be sensitive when the same zippers are expressed on both 
f'usion proteins. Their interaction with the mutants is unknown. The tetracycline resistant 
controls are pJH541, pXZ1090, and pAH4099. pJH541 is the tetracycline resistant 
vector. It is used to make sure that the tetracycline resistant plasmids do not affect the 
expression of the ampicillin resistant plasmids. Any ampicillin resistant plasmid, except 
pJH706, paired with pJH541 should be immune to phage J, . pXZ1090 and pAH4099 
contain the dominant negative N-terminal domain of cI repressor fused to an a position 
mutant of the GCN4 leucine zipper. pXZ1090 contains the same zipper as pXZ1130 and 
pAH4099 contains the same zipper as pAH4083. These mutants are immune to infection 
when expressed with wild-type GCN4. Cells containing the wild-type ampicillin resistant 
plasmid and one of these two plasmids will be immune to infection. When they are 
expressed with the ampicillin resistant plasmid with the same zipper they will be sensitive. 
Their interaction with the mutants is unknown. 
Plasmids with cI' fusions were introduced into cells containing the dominant 
negative fusions by M13-mediated transduction. A single colony of cells containing each 
cI' fusion plasmid was used to inoculate overnight cultures in LB ampicillin. 20ltL of the 
overnight culture was mixed with O. ImL of a 1: 10 dilution of phage M13 rv-1(original 
titer 2x10"pfu/mL). This mixture was incubated for 10 minutes at 37 C. 2mL of 2x YT 
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broth (16g Tryptone, 10g yeast extract, 10g NaCl per liter) was added to the mixture and 
the cells were grown for 8 hours with aeration. The cells were spun down in a microfuge 
for 10 minutes. The supernatant containing the M13 transducing phage was removed to a 
new tube and incubated for 15 minutes at 60'C to kill any remaining cells. Recipients 
were prepared by using a single colony of cefis containing each dominant negative fusion 
plasmid to inoculate overnight cultures in LB tetracycline. 50isL of each overnight was 
mixed with 5ltL of each cl' fusion M13 transducing stock, to make all possible 
combinations of cI' and dominant negative fusions. The mixtures were incubated at 37'C 
for 30 minutes. SltL of each transduction was spotted on an LB ampicillin/tetracycline 
plate. After the spot dried, it was struck out for single colonies. The single colonies that 
grew were struck for singles again the next day. These single colonies were used in the 
specificity assays. 
Specificity Assays 
The specificity of the mutants was tested using 3, repressor gene fusions. The gene 
fusion technique modifies the properties of proteins that do not give detectable phenotypes 
so that the protein expresses a detectable phenotype. The A repressor is a homodimer with 
two doinains. The N-domain is for DNA binding and the C-domain is for dimerization. 
When the C-domains dimerize, they form the functional A repressor by bringing the N- 
domains together in the correct arrangement to allow DNA binding. When X repressor 
binds to DNA, it prevents transcription of the X DNA which prevents expression of genes 
in the lytic pathway. These cells that contain dimeric A repressor cannot be infected by 
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phage X. To test mutants that ordy form homodimers, the C-domain of L repressor was 
replaced with the leucine zipper domain of each mutant. The cells with functional leucine 
zippers being made are able to bind DNA and repress the lytic cycle so they are immune to 
inFection by phage L. To test mutants that can form either heterodirners or homodimers, 
this process must be modified slightly. The homodimeric A repressor was expressed in a 
cell along with the mutant leucine zipper attached to a dominant negative repressor mutant 
(Fig. 3). The dominant negative repressor mutant has a dominant mutation in A repressor 
that makes it unable to bind to DNA. In order for a cell to be immune to phage X, it must 
produce homodimeric wild-type A repressor. If heterodimers form, they will not be able 
to bind to the DNA, so the cell will be sensitive to infection by phage 2 [1995]. 
The plasmid containing cells were tested for immunity XKH54. A culture of the 
double plasmid cells was inoculated from a single colony and was grown in LB 
ampicillin/tetracycline at 37 C. When the first specificity assays were done, overnight 
cultures were used. A large number of the plaques were turbid, meaning not all of the 
cells in the plaque were being killed. I began using eight how cultures because this 
eliminated the presence of most turbid plaques in the immunity tests, Eight hour cultures 
were used in the specificity assays except where specifically noted. 50ltL of the culture 
was mixed with 2mL of tryptone top agar (10g tryptone, Sg NaC1, 13g Bacto-Agar per 
liter). The agar was poured onto an LB ampicillin plate. Tetracycline was omitted f'rom 
the plates because it was affecting the ability of the cells to be immune to phage A. 
Dilutions of XKH54 were spotted on the lawn. Strains that did not show any plaques 
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were considered immune; they form homodimers. Strains with clear or turbid plaques 
were considered sensitive, they form heterodimers at a high enough level to reduce the 
intracellular concentration of homodimers below the level required for immunity. 
Results 
Specificity assays with the original series of rntttants 
The specificity assays done by Zeng on the original series of mutants were 
repeated to make sure the results were valid [1997A]. The specificity of interactions 
between the original mutants and the wild-type was tested using A repressor gene fusions. 
The gene fusion technique modifies the properties of proteins that do not give detectable 
phenotypes so that the protein expresses a detectable phenotype. This assay is fairly quick 
to carry out so very large numbers of mutants can be tested at one time. To test if the 
mutants are forming either heterodimers or homodimers, the homodimeric il, repressor is 
expressed in a cell along with the mutant leucine zipper attached to a dominant negative 
repressor mutant (Fig. 3). In order for a cell to be immune to phage X, it must produce 
homodimeric wild-type il. repressor. If beterodimers form, they will not be able to bind to 
the DNA, so the cell will be sensitive to infection by phage X [1995). The original tests 
were done by cross-streaking with AKH54. The tests were redone using the more 
sensitive plating method described in materials and methods. The tests pairing the mutants 
with the wild-type fusions and with the controls were done using 8 hour cultures, while 
the tests pairing the mutants with each other were done using overnight cultures. 
Figure 4 shows the results of the specificity assays, Each row shows the results for 
one cI' fusion protein expressed with one of the dominant negative fusion proteins in each 
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column. The results of the assays I did are shown in the big boxes. The results of the 
assays done by Zeng are shown in small boxes inside the big boxes. Zeng's results are 
only shown if his result differed from the result I obtained. 
The control plasmids all gave the expected results. Each of the dominant negative 
fusions paired with p JH706 was sensitive to infection by phage J, . This result is correct 
because p JH706 contains the DNA binding domain of the 434 repressor fused to the 
GCN4 leucine zipper so it cannot confer immunity to phage A. All of the cI' fusions, 
except p JH706, paired with p JH541 were immune to infection by phage J . This result is 
correct because it shows that the tetracycline resistant vector, pJH541, does not affect the 
expression of the cI' fusions and it does not affect the ability of the cell to be immune to 
phage J, . The a position mutants were immune to infection when paired with wild-type 
GCN4 and sensitive to infection when paired with themselves (he. XZ1130 with XZ1090 
was sensitive and AH4083 with AH4099 was sensitive). The a position mutants were 
immune when paired with the mutants, indicating the a position mutants could not interact 
with the mutants. 
Zeng found that all of the mutants were inunune when paired with the wild-type 
fusions, meaning the mutants and the wild-type leucine zippers were unable to interact 
with each other. My results show that the mutants paired with the wild-type are immune 
to infection, except for n34. The cI' fusion of n34 was sensitive when paired with the 
dominant negative fusion of the wild-type, but the n34 dominant negative fusion was 
unable to inhibit the cI' fusion of the wild-type. My results confirm that overall the 
mutants are unable to interact with the wild-type. 
15 
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The boxes along the diagonal show combinations where the same leucine zipper is 
present in both fusion proteins. Zeng found that the wild-type and all of the mutants were 
sensitive to infection when the same zipper was expressed on both fusion proteins. My 
results confirmed that the wild-type, n34, s20, s24, and s67 were sensitive to infection. 
My results for s03, s26, s56 and s64 show that the cells are immune to infection when the 
same zipper is expressed on both fusion proteins. 
Zeng's results and my results differ greatly when the mutants are paired with each 
other. Of the 81 possible combinations, there were 30 discrepancies. The nature and 
possible origin of these discrepancies are described in the discussion. 
Canstrttction af the alanine tnrttants 
To test the importance of the e13 and g29 leucine residues in wild-type GCN4 on 
the dnnerization specificity, a series of mutants containing alanine instead of leucine at 
these positions was constructed. The mutant and wild-type zippers were fused to the DNA 
binding domain of X cl repressor (cl+ fusions). These fusion proteins are expressed in E. 
coli from a weak constitutive promoter, P7107. Cells that express dimeric cl' fusions are 
immune to infection by phage X. The leucine zippers will form dimers that bind to the A 
DNA, preventing it from being transcribed. Cells that express monomeric cl' fusions are 
sensitive to infection by phage X. Each of the mutants and wild-type cI' fusion proteins 
were tested by cross-streaking with XKH54 to make sure they were forming stable dimers. 
The mutant and wild-type zippers were subcloned into a plasmid containing the 
DNA binding domain of A cI repressor with two mutations that make it unable to bind to 
DNA (dominant negative fusions). The cl' fusions and the dominant negative fusions 
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were expressed in the same cell using M13-mediated transduction as described in materials 
and methods. 
Construction of the leucine mutants 
A second series of mutants was constructed by adding leucine residues to three of 
the mutants in the original series. The three mutants chosen, s20, s26, and s67, contained 
alanine at two or three positions. The cl' fusion of the s20 leucine mutant has been 
constructed the same way the alanine mutants were made. The other mutants are in the 
process of being made and then their specificity will be tested to each other, the wild-type 
GCN4 and the original series of mutants. 
Spectftci ty assay results of the alanine mutants rei th each other 
The results of phage immunity tests on the alanine mutants expressing pairwise 
combinations of wild-type and mutant leucine zippers are shown in Figure 5. Each row 
shows the results for one cl' fusion protein expressed with one of the dominant negative 
fusion proteins in each column. 
The control plasmids all gave the expected results. Each of the dominant negative 
fusions paired with p JH706 was sensitive to infection by phage X. All of the cI' fusions, 
except p JH706, paired with p JH541 were immune to infection by phage J, . The a position 
mutants were immune to infection when paired with wild-type GCN4 and sensitive to 
infection when paired with themselves. The a position mutants were immune when paired 
with the rnutants, indicating the a position mutants could not interact with the alanine 
mutants. 
17 
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The cI' fusion of the wild-type GCN4 zipper was sensitive when paired with its 
dominant negative fusion, indicating that heterodimers are forming. The wild-type is able 
to interact with itself. The wild-type paired with each of the mutants was sensitive to 
infection, indicating that the mutants and the wild-type are forming heterodimers. 
The cI' fusion of AL was immune to infection when paired with the dominant 
negative fusion of the wild-type. This result suggests that AL is not able to interact with 
the wild-type by forming heterodimers. The cl' fusion of AL was immune when paired 
with its own dominant negative fusion. Since AL must be able to interact with itself, this 
suggests something else is happening (see discussion). The cI' fusion of AL was inunune 
when paired with the dominant negative fusion of LA and is sensitive when paired with the 
dominant negative fusion of AA. The dominant negative fusion of AL inhibits repression 
by the cI' fusions of wild-type and LA. 
The cI' fusion of LA is sensitive when paired with the dominant negative fusions 
of the wild-type, AL, and AA, indicating that it can form heterodirners with each one. The 
cI' fusion of LA was sensitive when paired with its own dominant negative fusion„ 
indicating that it is able to interact with itself. The dominant negative fusion to LA inhibits 
repression by cl' fusions to wild-type but not the AL or AA mutants. 
Like the LA mutant, the cI' fusion of AA is sensitive when paired with the 
dominant negative fusion of the wild-type, suggesting that it is able to interact with the 
wild-type. The cI' fusion of AA was immune when paired with the dominant negative 
fusion of AL and LA, suggesting that it is also unable to interact with them. The cl' fusion 
of AA was sensitive when paired with its dominant negative fusion, indicating that it is 
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able to interact with itself. However, the dominant negative fusion of AA inhibited 
repression of wild-type, AL, LA and itself. 
Specificity assay resttlts of the alanine mtttants with the origi nal mtttants 
The specificity of each alanine mutant was also tested with the original series of 
mutants. The results of the specificity assay using the cl' fusion of the alanine mutants 
and the dominant negative fusion of the original series of mutants is shown in Figure 6. 
The control plasmids all gave the expected results. Each of the dominant negative fusions 
paired with pJH706 was sensitive to infection by phage J, . The a position mutants, 
XZ1130 and AH4083, were immune when paired with the mutants, indicating that they 
could not interact with the mutants. All combinations of the wild-type and alanine 
mutants paired with the original mutants were immune to infection by phage X. These 
results indicate that the alanine mutants cannot form heterodimers with the original series 
of mutants. 
The results of the specificity assay using the cl' fusions of the original mutants and 
the dominant negative fusions of the alanine mutants is shown in Figure 7. The control 
plasmids all gave the expected results. Each of the dominant negative fusions paired with 
p JH706 was sensitive to infection by phage J. . The a position mutants, XZ1130 and 
AH4083, were immune when paired with the mutants, indicating that they could not 
interact with the mutants. All of the combinations were immune to infection by phage J. , 
except n34 with wild-type, s56 with AL and s67 with AL. These results indicate that 
overall the alanine mutants do not interact with the original series of mutants. 
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Discussion 
The sequence of the 67 naturally occurring leucine zippers identified as of 1994 
[1994] was analyzed to determine the number of leucines occurring in the e and g 
positions. Only three zippers were found that contain two leucines at the e and g positions. 
One zipper was found that contains three leucines. This shows that the leucines present in 
GCN4 are not usually found in the naturally occurring leucine zippers. 
Despite the observed discrepancies, the specificity assays done with the original 
series of mutants show the same general trend as the assays done by Zeng. The wild-type 
is specific, it will only dimerize with itself. The mutants are promiscuous; most of the 
mutants will dimerize with each other. There were many discrepancies in the assays 
testing the mutants with each other. Some reasons for these discrepancies are that the 
original tests done by Zeng were done by cross-streaking and the tests I conducted were 
done by spotting dilutions of phage on a lawn of cells. Also, the tests pairing the mutants 
with the wild-type fusions and with the controls were done using 8 hour cultures, while 
the tests pairing the mutants with each other were done using overnight cultures. I will 
redo the assays of the mutants with each other using 8 hour cultures to determine if this 
changes the results. Even though these discrepancies exist, the results of my assays and of 
Zeng's assays show that the mutants are promiscuous, meaning they dimerize with each 
other and the wild-type is very specific, meaning it will only dimerize with itself and not 
the mutants. The results of my specificity assays show that there is a difference in the 
dimerization specificity of the wild-type and the mutants. 
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The specificity assays done with the alanine mutants show several interesting 
results. The AL mutant was immune when it was expressed in the same cell on both 
fusion proteins. Similar results were seen with other mutants in our lab when tetramers 
were being formed instead of dimers [1997C]. The tetramer can still bind to the phage A 
DNA and confer immunity as long as it contains two wild-type copies of the DNA binding 
domain. The AL mutant will be tested for tetramer formation using the assay in Figure 8. 
Two reporter strains are used. The strain on the lefi has two operators. The weak 
operator overlaps the promoter for lacZ, which codes for p-galactosidase and car, which 
confers chloramphenicol resistance. The strong operator site is upstream of the weak 
operator and does not affect transcription by the promoter. Cooperative binding to both 
of these promoters increases the efficiency of repression. The second reporter strain, 
shown in the middle of the picture, contains one weak promoter that overlaps the 
promoter for lacZ and car. Repression of the lacZ gene is measured using a p- 
galactosidase assay. The top of Figure 8 gives an example of a dimeric fusion protein. On 
the right, the dimeric protein does not have a high enough afimity to bind to the weak 
operator. The graph shows the level of P-galactosidase activity For the wild-type dimer is 
repressed to 60% for one operator. On the lefi, the dimeric fusion will bind to the strong 
operator. The dimeric protein does not have a high enough affinity to bind to the weak 
operator. The level of P-galactosidase activity for the wild-type dimer is repressed to 40% 
for two operators. The bottom of the figure gives an example of a tetrameric fusion 
protein. On the right, the tetrameric protein does not have a high enough aflinity to bind to 
the weak operator. The graph shows the level of P-galactosidase activity for the aLdl 
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tetramer is repressed to 40'/o for one operator. On the left, the binding of two DNA 
binding domains to the strong operator brings the other two DNA binding domains into a 
configuration that allows them to bind to the weak operator. The cooperative binding of 
the tetrameric fusion protein to both operators represses the level of P-galactosidase 
activity to less than 10'. This assay allows tetrameric and dimeric fusion proteins to 
distinguished phenotypically based on the ability of tetrameric fusions to bind 
cooperatively to adjacent operator sites. 
The dominant negative fusion of AA was the only combination that was sensitive 
to infection when paired with the cf fusion of AL. This result can also be explained by 
formation of tetramers. Consider a situation where the dominant negative fusion of AA 
forms dimers and the cI' fusion of AL forms tetramers. When the two fusion proteins are 
expressed in the same cell, they are able to interact. The resulting fusion protein could be 
a dimer, tetramer or higher order oligomer. As long as the dimer contains one dominant 
negative DNA binding domain the cell will be sensitive to infection. As long as a tetramer 
or higher order oligomer contains enough copies of the dominant negative DNA binding 
domain to make it inactive, the cell will be sensitive to infection. 
The working hypothesis predicted that the leucine residues at positions e13 and 
g29 were causing the wild-type GCN4 to be more specific. By replacing the leucine 
residues with alanine, the new series of mutants would be more similar to the original 
series of mutants. If the leucines are causing the difference in specificity, then the new 
mutants should be able to dimerize with the original series of mutants and should not be 
able to dimerize with the wild-type GCN4. Instead, removing those leucine residues and 
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replacing them with alanine allowed the mutants to dirnerize with the wild-type but not 
with the original set of mutants. This result indicates that the leucines are not sufficient to 
explain the differences in dimerization specificity. Thus, our working hypothesis was 
shown to be incorrect based on the results of the specificity assays. 
The properties of the AL and AA mutants suggest that leucine at position e13 may 
be involved in causing the wild-type leucine zipper to prefer dimers over other 
oligmerization states. We cannot rule out the possibility that the leucines do have some 
effect on the dimerization specificity due to the limitations of the specificity assay. The 
new series of alanine mutants may be less promiscuous than the original series of mutants 
and still have a different specificity than the wild-type. These degrees of interaction 
cannot be determined by the assay used here, we plan to do a quantitative measurement of 
heterodimer formation i n vitro. 
Nevertheless, my results suggest that the difference in dimerization specificity 
between the mutants and the wild-type is due to the pattern of amino acids in the e and g 
positions. A specific pattern of positively charged, negatively charged and neutral amino 
acids may be required in order to see the specificity exhibited by the wild-type GCN4 
leucine zipper and the promiscuity exhibited by the mutants. 
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Table l. e and g sequence of mutants in the original series 
mutant e/g sequence 
n3 4 KKTK/AAEA 
s03 KEKT/KEAE 
s20 EEAE/KKAA 
s24 ~ETA 
s26 AEAE/KKKE 
s56 EKTA/EKTK 
s64 ATKK/AEET 
s67 KKEA/EKEA 
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Table 2. The alanine mutants 
Mutant name 
LL 
LA 
Mutated positions 
wild-type 
e13 
g29 
el3 and g29 
e/g sequence 
ELEK/KKEL 
EAE~L 
ELEK/KKEA 
EAEK/KKEA 
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Table 3. The leucine mutants 
Mutant name Mutated positions original e/g mutated e/g 
sequence sequence 
s20L eZO, g22, and g29 EEAE/KKAA EELE/KKLL 
s26L 
s67L 
e6' and e20 
e27 and g29 
AEAE/KKKE LELE/KKKE 
KKEA/EKE A KKEL/EKEL 
Rieker 
Table 4. Oligos used to make alanine and leucine mutants 
Oligo name 
WT N-terminal 
WT C-terminal 
L13 A N-terminal 
: 'Description 
N-terminal half containing the wild 
i type zipper and a Sall site 
i C-terminal half containing the wild 
:: type zipper and a BamHI site 
N-terminal half containing LI3A 
mutation and a Sall site 
: 'Sequence' 
GAGAGATGGGTGTCGACACATATGAAAC 
AGCTGGAAGACAAAGTf GAAGACTGCGC 
5 TTCTAAAAAC 
! 
AGCAGCGCCGGATCCTCAACGTTCACCAA 
i CTAGTTITITCAGGCGCGCAACTICGTICT 
R CGAGGTGGTAGTTITfAGA 
GAGAGATGGGTGTCGACACATATGAAAC 
AGCTGGAAGACAAAGTI'GAAGAGCTCGC 
L29A C-terminal 
s20L N-terminal 
s20L C-terminal 
s26L ¹erminal 
s26L C-terminal 
s67L N-terminal 
s67L C-terminal 
C-terminal half containing L29A 
mutation and a BamHI site 
N-terminal half of s20 mutant 
containing a Sall site 
C-terminal half of s20 mutant 
containing the A20L, A22L, and 
A29L mutations and a BamHI site 
N-terminal half of s26 mutant 
containing A6L mutation and a Sall 
stte 
C-terminal half of s26 mutant 
containing A20L mutation and a 
BamHI site 
N-terminal half of s67 mutant 
: containing a SalI site 
C-terminal half of s67 mutant 
containing A27L and A29L 
mutations and a BnmHI site 
AGCAGCGCCGGATCCTCAACGTTCACCAA 
': CAGCTITITI'CAGGCGCGCAACTTCGTI'C 
I TCGAGGTGGTAGTTTTTAGA 
GAGAGATGGGTGTCGACACATATGAAAC 
AGCTGGAAGACAAAGTTGAAGAGCTCGA 
ATCTAAAAAC 
AGCAGCGCCGGATCCTCAACGTI'CACCAA 
CCAGTTIITCCAGGCGCGCAACCAGGTTC 
AGGAGGTGGTAGTITITAGA 
GAG AGATGGGTGTCGACACATATGAAAC 
AGCTGCTGGACAAAGTI'GAAGAGCT CGA 
ATCTAAAAAC 
AGCAGCGCCGGATCCTCAACTTTCACCAA 
CTT~CCAGGCGCGCAACTTTGTTCA 
GGAGGTGGTAG~AGA 
GAGAGATGGGTGTCGACACATATGAAAC 
AGCTGAAAGACGAAGTI'GAAGAGCTCAA 
ATCTAAAAAC 
AGCAGCGCCGGATCCTCAACGTf CACCAA 
CCAGTITCAGCAGGCGCGCAACITCGTIT 
TCGAGGTGGTAGTITITAGA 
'The underlined nucleotides indicate bases that were changed to make the mutations. 
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Figure Legends 
Figure L The leucine zipper of GCN4. 
A. The sequence of the wild-type GCN4 leucine zipper. The lower case letters indicate 
the positions in the heptad repeat. The e and g positions are indicated by outline font, 
B. Each u-helix is represented by a cylinder with a dotted line showing the path of the 
polypeptide chain. The side chains of the amino acids are represented by circles. The e' 
and g positions are highlighted to show how salt bridges can form between charged amino 
acids at the e' position of one heptad and the g position of the next heptad. 
C. An end view of the dimer. The residues of one monomer are labeled abcdefg and the 
corresponding residues of the other monomer are labeled a'b'c'd'e J'g'. The a and d 
residues form the hydrophobic surface where the two a-helices come together. The e and 
g positions are on the side of the dirner, so they can interact by forming salt bridges. 
Figure 2. The molecular haircut 
Leucine has a long hydrophobic side chain. The interactions of this side chain at e13 and 
g29 in the wild-type GCN4 can be eliminated by substituting alanine in these positions in 
the mutants. 
Figure 3. The specificity assay for testing heterodimer formation. 
The homodimeric 2, repressor (white circle with striped zipper) is expressed with the 
mutant leucine zipper attached to a dominant negative repressor mutant (poison circle 
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with white zipper). If the cell only produces homodimers, then the cell will be immune to 
phage A infection. If heterodimers form, the cell wiH be sensitive to infection by phage A. 
Figure 4. Specificity assay results for the original series of mutants 
Each row shows the results for one cI' fusion protein expressed with one of the dominant 
negative fusion proteins in each column. The results of the assays I did are shown in the 
big boxes. The results of the assays done by Zeng are shown in small boxes inside the big 
boxes. Zeng's results are only shown if the result dilfered from the result I obtained. The 
boxes along the diagonal show combinations where the same leucine zipper is present in 
both fusion proteins. Boxes on the diagonal that were sensitive to infection by phage X 
are black. Gray boxes indicate combinations that were sensitive to infection. White boxes 
indicate combinations that were immune to infection. 
Figure 5. Specificity assay results for the alanine mutants tested with each other 
The wild-type and mutants are designated by their e13/g29 sequence (L = leucine, A = 
alanine). The shading codes are the same as Figure 4. 
Figure 6. Specificity assay results for the cl' fusion of the alanine mutants with the 
dominant negative fusion of the original series of mutants 
The shading codes are the same as Figure 4. 
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Figure 7. Specificity assay results for the cl fusion of the original series of mutants with 
the dominant negative fusion of the alanine mutants 
The shading codes are the same as Figure 4. 
Figure 8. Tetramer assay 
This assay allows tetrameric and dimeric fusion proteins to distinguished phenotypically 
based on the ability of tetrameric fusions to bind cooperatively to adjacent operator sites. 
Two reporter strains are shown, one on the left and one on the right. The dimeric protein 
in the strain on the right does not have a high enough affinity to bind to the weak operator. 
The graph shows that the level of P-galactosidase activity for the wild-type dimer is 
repressed to 60'to for one operator. The dimeric fusion in the strain on the leff will bind to 
the strong operator. The dimeric fusion protein does not have a high enough affinity to 
bind to the weak operator. The level of P-galactosidase activity for the wild-type dimer is 
repressed to 40'/o for two operators. The tetrameric protein in the strain on the right does 
not have a high enough affmity to bind to the weak operator. The graph shows the Ieve& 
of P-gslactosidase activity for the aLdl tetramer is repressed to 40'lo for one operator. In 
the strain on the left, the binding of two DNA binding domains to the strong operator 
brings the other two DNA binding domains into a configuration that allows them to bind 
to the weak operator. The cooperative binding of the tetrameric fusion protein to both 
operators represses the level of P-galactosidase activity to less than IP/o. 
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Figure 1. The leucine zipper of GCN4 
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Figure 2. The molecular haircut 
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Figure 3. The specificity assay 
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Figure 4. Specificity assays using the original series of mutants 
Dominant negative fnsions 
LL n34 s03 s20 s24 s26 s56 s64 s67 JH541 XZ1090 AH4099 
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Figure 5. Specificity Assays using alanine mutants with each other 
Dominant negative fusions 
LL AL LA AA JH541 XZ1090 AH4099 
LL 
LA 
cI' fusions AA 
JH 706 
XZ1130 
AH4083 
itnmune 
W sensitive 
self-titration 
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Figure 6. Specificity Assays using cI' fusion of alanine mutants with the dominant 
negative fusion of the original series of mutsnts 
Dominant negative fusions 
n34 s03 s20 s24 s26 s56 s64 s67 
LL 
LA 
cI fusions AA 
JH 706 
XZ1130 
AH4083 
immune 
R sensitive 
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Figure 7. Specificity Assays using cI' fusion of the original series of mutants with the 
dominant negative fusion of the alanine mutants 
Dominant negative fusions 
LL AL LA AA 
LL 
s03 
s20 
s24 
cI' fusions 
s26 
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JH706 
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Figure 8. Tetramer assay 
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